Biblio

Found 56 results

Author Keyword Title Type [ Year

]

Filters: Keyword is Genetic Predisposition to Disease [Clear All Filters]

2014

Cruchaga C, Karch CM, Jin SChih, Benitez BA, Cai Y, Guerreiro R, Harari O, Norton J, Budde J, Bertelsen S et al.. 2014. Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.. Nature. 505(7484):550-554.

2013

Ridge PG, Mukherjee S, Crane PK, Kauwe JSK. 2013. Alzheimer's disease: analyzing the missing heritability.. PLoS One. 8(11):e79771.

Thambisetty M, An Y, Tanaka T. 2013. Alzheimer's disease risk genes and the age-at-onset phenotype.. Neurobiol Aging. 34(11):2696.e1-5.

Reitz C, Tosto G, Vardarajan B, Rogaeva E, Ghani M, Rogers RS, Conrad C, Haines JL, Pericak-Vance MA, Fallin MD et al.. 2013. Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP).. Transl Psychiatry. 3:e256.

Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, DeStafano AL, Bis JC, Beecham GW, Grenier-Boley B et al.. 2013. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.. Nat Genet. 45(12):1452-8.

Reitz C, Jun G, Naj A, Rajbhandary R, Vardarajan BNarayan, San Wang L-, Valladares O, Lin C-F, Larson EB, Graff-Radford NR et al.. 2013. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans.. JAMA. 309(14):1483-92.

2012

Zou F, Chai HSeng, Younkin CS, Allen M, Crook J, V Pankratz S, Carrasquillo MM, Rowley CN, Nair AA, Middha S et al.. 2012. Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants.. PLoS Genet. 8(6):e1002707.

Kamboh MI, Barmada MM, Demirci FY, Minster RL, Carrasquillo MM, Pankratz VS, Younkin SG, Saykin AJ, Sweet RA, Feingold E et al.. 2012. Genome-wide association analysis of age-at-onset in Alzheimer's disease.. Mol Psychiatry. 17(12):1340-6.

2011

Hollingworth P, Harold D, Sims R, Gerrish A, Lambert J-C, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JSingh, Moskvina V et al.. 2011. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.. Nat Genet. 43(5):429-35.

Naj AC, Jun G, Beecham GW, San Wang L-, Vardarajan BNarayan, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK et al.. 2011. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.. Nat Genet. 43(5):436-41.

Logue MW, Schu M, Vardarajan BN, Buros J, Green RC, Go RCP, Griffith P, Obisesan TO, Shatz R, Borenstein A et al.. 2011. A comprehensive genetic association study of Alzheimer disease in African Americans.. Arch Neurol. 68(12):1569-79.

Höglinger GU, Melhem NM, Dickson DW, Sleiman PMA, San Wang L-, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE et al.. 2011. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.. Nat Genet. 43(7):699-705.

2010

Reynolds CA, Hong M-G, Eriksson UK, Blennow K, Wiklund F, Johansson B, Malmberg B, Berg S, Alexeyenko A, Grönberg H et al.. 2010. Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk.. Hum Mol Genet. 19(10):2068-78.

Corneveaux JJ, Myers AJ, Allen AN, Pruzin JJ, Ramirez M, Engel A, Nalls MA, Chen K, Lee W, Chewning K et al.. 2010. Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.. Hum Mol Genet. 19(16):3295-301.

Fallin MDaniele, Szymanski M, Wang R, Gherman A, Bassett SS, Avramopoulos D. 2010. Fine mapping of the chromosome 10q11-q21 linkage region in Alzheimer's disease cases and controls.. Neurogenetics. 11(3):335-48.

2009

Carrasquillo MM, Zou F, V Pankratz S, Wilcox SL, Ma L, Walker LP, Younkin SG, Younkin CS, Younkin LH, Bisceglio GD et al.. 2009. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease.. Nat Genet. 41(2):192-8.

Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JSingh, Moskvina V, Dowzell K, Williams A et al.. 2009. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.. Nat Genet. 41(10):1088-93.

Beecham GW, Martin ER, Li Y-J, Slifer MA, Gilbert JR, Haines JL, Pericak-Vance MA. 2009. Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease.. Am J Hum Genet. 84(1):35-43.

2008

Lee JH, Cheng R, Graff-Radford N, Foroud T, Mayeux R. 2008. Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci.. Arch Neurol. 65(11):1518-26.

Bertram L, Lange C, Mullin K, Parkinson M, Hsiao M, Hogan MF, Schjeide BMM, Hooli B, Divito J, Ionita I et al.. 2008. Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE.. Am J Hum Genet. 83(5):623-32.

Lee JH, Barral S, Reitz C. 2008. The neuronal sortilin-related receptor gene SORL1 and late-onset Alzheimer's disease.. Curr Neurol Neurosci Rep. 8(5):384-91.

2007

Reiman EM, Webster JA, Myers AJ, Hardy J, Dunckley T, Zismann VL, Joshipura KD, Pearson JV, Hu-Lince D, Huentelman MJ et al.. 2007. GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.. Neuron. 54(5):713-20.

2006

Li Y-J, Scott WK, Zhang L, Lin P-I, Oliveira SA, Skelly T, Doraiswamy MP, Welsh-Bohmer KA, Martin ER, Haines JL et al.. 2006. Revealing the role of glutathione S-transferase omega in age-at-onset of Alzheimer and Parkinson diseases.. Neurobiol Aging. 27(8):1087-93.

2005

Lohoff FW, Sander T, Ferraro TN, Dahl JP, Gallinat J, Berrettini WH. 2005. Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder.. Am J Med Genet B Neuropsychiatr Genet. 139B(1):51-3.

Ertekin-Taner N, Ronald J, Feuk L, Prince J, Tucker M, Younkin L, Hella M, Jain S, Hackett A, Scanlin L et al.. 2005. Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene.. Hum Mol Genet. 14(3):447-60.